| This is a routine Activity In My Practice |
1. Assess and document asthma severity at initial visit and update severity when wellcontrolled based on lowest therapy step required (intermittent, mild, moderate or severe persistent) |
|
2. Use a step wise approach for prescribing controller therapy including EPR4 recommendations for Single Maintenance and Reliever Therapy (SMART) when appropriate. https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/clinician-guide-2020-focused-updates-asthma-management-guidelines |
|
3. Assess and document asthma control at every visit (well controlled, not wellcontrolled, or very poorly controlled), step up or step down therapy when indicated. |
|
4. Assess, interpret and document FEV1 for all patients age 5 years and older at eachvisit (use GLI lung calculator to determine % predicted).http://gligastransfer.org.au/calcs/spiro.html |
|
5. Order and evaluate spirometry every 1-2 years for all patients 6 years and older (FVC, FEV1, and FEF25-75). Determine lung growth pattern and evidence for lung function impairment by tracking FEV1% predicted over time and ensuring the FEV1/FVC ratio is near 85 or refer. |
|
6. Assess adequacy of inhalation technique for ICS and SABA inhalers. Use samemethod for medication delivery of ICS & SABA - either MDI* or DPI for both. Documentinspiratory ow rate and time before and after coaching. Use Aerochamber Plus® Flow-Vu® for MDIs. https://www.aerochambervhc.com/ *preferred |
|
7. Patients (or caregivers) complete a validated asthma control test at each visit: Testfor Respiratory and Asthma Control in Kids© [TRACK] (0-4 years) Asthma Control Test©(ACT), 4-11 version or ACT 12 & older version for youths & adults |
|
8. For patients with persistent asthma confirm the last 3 ICS dispensing dates to determine if supply is adequate for good adherence (call pharmacy, review EMR external Rx history or claims data using CyberAccess for Medicaid patients). Note excessive SABA, systemic steroid and antibiotic dispensing patterns. |
|
9. For uncontrolled asthma with good inhaler technique, adequate ICS supply and good adherence, complete an asthma trigger screening tool. https://www.neefusa.org/resource/asthma-environmental-history-form. Refer for environmental assessment & education. www.asthmabridge.com Document key steps to reduce triggers. |
|
10. For uncontrolled asthma document clinical history, results and treatment of allergic rhinitis (inhalant antigen prick testing or ImmunoCAP® for inhalant antigens), gastroesophageal reflux disease, overweight, obstructive sleep apnea, vocal cord dysfunction and other co-morbidities. |
|
11. All patients receive a written asthma action plan that documents peak ow ranges, best FEV1 on record, an ICS step plan and other yellow zone actions to manage co-morbidities, as well as indications for a 911 call and use of albuterol 6 puffs by valved holding chamber for life-threatening asthma |
|
12. All patients have a “key messages” dashboard to ensure delivery and documentation of critical guidance and counseling over the first 3 asthma visits and additional education thereafter. |
|